18 September 2026
Aspen's turnaround hinges on filling its underused sterile manufacturing plants, as GLP-1 sales drive a share recovery.
23 August 2026
The pharmaceutical manufacturing crisis is worsening as procurement policies, rising costs, and imports threaten medicine supply.
22 August 2026
Pharmaceutical localisation talks target pricing reform, investment incentives, medicine security and stronger local manufacturing.
13 August 2026
Explore the calls for drug company nationalisation in South Africa amid rising job cuts and concerns in the pharmaceutical industry.
23 July 2026
Generic drug tariffs could raise US medicine costs, disrupt global supply chains and pressure manufacturers to move production to America.
21 July 2026
Aspen Semaglutide Canada gains Health Canada approval, but API supply problems could delay the generic’s commercial launch.
10 July 2026
Aspen Chair Transition will see Ben Kruger replace Kuseni Dlamini as Aspen Pharmacare prepares for debt-free growth and new investment.
2 June 2026
SA pharma localisation faces hurdles as Trade Minister warns against foreign investor conditions that undermine domestic procurement.
19 May 2026
Biovac vaccine tender secures a vital R5.3bn state contract for Hexaxim, driving Africa's local manufacturing goals.
8 May 2026
Aspen Insulin approval marks a milestone for diabetes care in South Africa, ensuring supply security with locally made insulin.
26 March 2026
Lenacapavir manufacturing in SA aims to strengthen supply chains and provide critical HIV prevention solutions.